GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties can help alleviate symptoms of long Covid.
Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of editing human embryos to make disease-free children.
Another round of terminations, combined with previous layoffs and departures, has reduced the Centers for Disease Control and Prevention workforce by about 3,000 people since January.
California-based Cognixion is launching a clinical trial to allow paralyzed patients with speech disorders the ability to communicate without an invasive brain implant.
In a chaotic meeting, ACIP voted not to recommend a prescription requirement for Covid-19 vaccines. Some panelists seemed unaware of the point of the meeting, while others went on strange tangents.
The vaccine advisory group ACIP, not all members of which seemed to know what the group does, recommended to the CDC that combined MMRV shots not be given before age 4.
Susan Monarez told a Senate committee that Robert F. Kennedy Jr. demanded she dismiss career officials without cause—and accept vaccine recommendations regardless of whether science backed them up.
At the WIRED Health summit, biochemist David Liu said his lab is on the verge of revealing a new gene-editing technique that could target multiple unrelated diseases.
The brain implant company cofounded by Elon Musk filed to trademark the product names Telepathy and Telekinesis. But it turns out that another person had already filed to trademark those names.
A new policy document outlines China’s plan to create an internationally competitive BCI industry within five years, and proposes developing devices for both health and consumer uses.
HHS is slashing hundreds of millions in funding for mRNA vaccines and infectious disease treatments, but leaving the door open to mRNA therapies for cancer and genetic conditions.
As federal vaccine policy shifts under US health secretary Robert F. Kennedy Jr., lawmakers are looking to give state-level public health officials authority to ignore federal recommendations.